Get the Stockscreener App
1.15
0.88%
0.01
Iridex Corp stock is traded at $1.15, with a volume of 19,054.
It is up +0.88% in the last 24 hours and up +22.25% over the past month.
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
See More
Previous Close:
$1.14
Open:
$1.17
24h Volume:
19,054
Relative Volume:
0.23
Market Cap:
$19.98M
Revenue:
$48.43M
Net Income/Loss:
$-11.04M
P/E Ratio:
-1.7164
EPS:
-0.67
Net Cash Flow:
$-7.00M
1W Performance:
-3.36%
1M Performance:
+22.25%
6M Performance:
-17.27%
1Y Performance:
-59.65%
1-Day Range:
$1.15
$1.17
1-Week Range:
$1.14
$1.22
52-Week Range:
$0.782
$3.25
Iridex Corp Stock (IRIX) Company Profile
Name
Iridex Corp
Sector
Industry
Phone
(650) 940-4700
Address
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Compare IRIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.15 | 19.98M | 48.43M | -11.04M | -7.00M | -0.67 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-17 | Resumed | ROTH Capital | Buy |
| Dec-21-16 | Initiated | ROTH Capital | Buy |
| Jan-26-16 | Initiated | Singular Research | Buy |
| Jan-03-07 | Initiated | First Albany | Buy |
Iridex Corp Stock (IRIX) Latest News
IRIDEX Changes Course (NASDAQ:IRIX) - Seeking Alpha
Iridex corp director William Moore buys $24,143 in common stock By Investing.com - Investing.com Canada
Iridex corp director William Moore buys $24,143 in common stock - Investing.com
IRIDEX Corp Director William M. Moore Acquires 20,000 Shares - TradingView
IRIDEX (NASDAQ:IRIX) Coverage Initiated by Analysts at StockNews.com - Defense World
IRIDEX (NASDAQ:IRIX) Now Covered by Analysts at StockNews.com - Defense World
Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025 - Yahoo Finance
IRIDEX Corporation (NASDAQ:IRIX) Q4 2024 Earnings Call Transcript - MSN
IRIDEX (NASDAQ:IRIX) Now Covered by StockNews.com - Defense World
IRIDEX Corp Board Reshuffles Following Novel Transaction - Investing.com Australia
Iridex to Host Strategic Vision Call on April 16, 2025 - Yahoo Finance
IRIDEX Corp Board Reshuffles Following Novel Transaction By Investing.com - Investing.com South Africa
IRIDEX Director Resigns to Comply with Rights Agreement - Investing.com
Reviewing IRIDEX (NASDAQ:IRIX) & CeriBell (NASDAQ:CBLL) - Defense World
StockNews.com Begins Coverage on IRIDEX (NASDAQ:IRIX) - Defense World
Iridex: Q4 Earnings Snapshot - MySA
IRIDEX Corp (IRIX) Q4 2024 Earnings Call Highlights: Strategic Investments and Revenue Growth ... - Yahoo
IRIDEX Corp (IRIX) Q4 2024 Earnings Call Highlights: Strategic I - GuruFocus
Iridex Corporation Reports Improved Financial Performance - TipRanks
IRIDEX earnings matched, revenue fell short of estimates - Investing.com
Earnings call transcript: IRIDEX Q4 2024 sees aftermarket stock surge - Investing.com
IRIDEX Corp Q4 2024 Earnings: EPS Meets Estimate at -$0.05, Reve - GuruFocus
IRIDEX Earnings Results: $IRIX Reports Quarterly Earnings - Nasdaq
Iridex Reports Fourth Quarter and Full Year 2024 Financial Results - Yahoo Finance
Earnings Preview For Iridex - Benzinga
IRIDEX Earnings Preview: Recent $IRIX Insider Trading, Hedge Fund Activity, and More - Nasdaq
IRIDEX (NASDAQ:IRIX) Shares Cross Below 200-Day Moving Average – Should You Sell? - Defense World
IRIDEX (NASDAQ:IRIX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Iridex secures $10 million investment for growth initiatives By Investing.com - Investing.com
Iridex Corporation Closes $10 Million Strategic Investment with Novel Inspiration International Co., Ltd. - Nasdaq
Iridex Announces Strategic Investment in the Company - GlobeNewswire
Iridex Stock: Volatility Persists Amid Stable Fundamentals - Sharewise
Iridex addresses recent stock volatility - Investing.com
Iridex Comments on Recent Stock Price Volatility - Yahoo Finance
Iridex Corporation to Announce Q4 and Full Year 2024 Financial Results on March 27, 2025 - Nasdaq
Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025 - GlobeNewswire Inc.
IRIDEX (NASDAQ:IRIX) Coverage Initiated at StockNews.com - Defense World
StockNews.com Initiates Coverage on IRIDEX (NASDAQ:IRIX) - Defense World
Iridex reports steady Q4 sales, eyes profitability in 2025 - Investing.com
Iridex Reports Mixed Q4 Results: Revenue Up, Achieves Positive EBITDA Amid Strategic Review - StockTitan
IRIDEX (NASDAQ:IRIX) Stock Passes Below 200 Day Moving Average – Time to Sell? - Defense World
Iridex Corp Stock (IRIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Iridex Corp Stock (IRIX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dizon Romeo R | Chief Financial Officer |
May 08 '25 |
Buy |
1.15 |
100 |
115 |
9,700 |
| Dizon Romeo R | Chief Financial Officer |
May 07 '25 |
Buy |
1.15 |
193 |
222 |
9,600 |
| Dizon Romeo R | Chief Financial Officer |
May 06 '25 |
Buy |
1.17 |
200 |
235 |
9,407 |
| Dizon Romeo R | Chief Financial Officer |
May 05 '25 |
Buy |
1.19 |
200 |
237 |
9,207 |
| MOORE WILLIAM M | Director |
Apr 29 '25 |
Buy |
1.21 |
19,710 |
23,784 |
121,150 |
| MOORE WILLIAM M | Director |
Apr 28 '25 |
Buy |
1.24 |
290 |
360 |
101,440 |
| Dizon Romeo R | Chief Financial Officer |
Apr 29 '25 |
Buy |
1.23 |
3,907 |
4,807 |
9,007 |
| Dizon Romeo R | Chief Financial Officer |
Apr 28 '25 |
Buy |
1.28 |
2,625 |
3,362 |
5,100 |
| Mercer Patrick | President and CEO |
Apr 28 '25 |
Buy |
1.29 |
7,500 |
9,705 |
400,790 |
| Mercer Patrick | President and CEO |
Apr 24 '25 |
Buy |
1.15 |
46 |
53 |
393,290 |
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):